Browsing Tag
Inc.
380 posts
How the GARDian3 trial could define the next commercial frontier in ophthalmic gene therapy
Discover how Ocugen, Inc.’s GARDian3 trial could redefine the commercial future of ophthalmic gene therapy and what investors should watch next.
How CLD-401 and RedTail may redefine tumor-localized immune activation in solid tumors
Can RedTail and CLD-401 change solid tumor immunotherapy? Read why Calidi Biotherapeutics, Inc.’s next milestones could reshape the CLDI story.
Could Newport Gold, Inc. and NFI Empire create a scalable OTC growth platform after the merger? (OTC.ID: NWPG)
Find out whether Newport Gold, Inc. and NFI Empire can turn this OTC merger into a scalable growth platform with real long-term shareholder upside.
Can United Airlines Holdings, Inc. turn fare complexity into a premium margin engine? (NASDAQ: UAL)
Find out how United Airlines Holdings, Inc. is redesigning premium fares to capture more revenue and reshape airline pricing strategy. Read more.
Why oncology investors are watching Cogent Biosciences, Inc.’s PEAK data closely
Why investors are closely watching Cogent Biosciences’ PEAK data and what bezuclastinib could mean for valuation, revenue growth, and oncology market sentiment.
Can Mobix Labs, Inc.’s mission-critical F-22 systems win drive long-term defense market upside? (Nasdaq: MOBX)
Can Mobix Labs, Inc.’s F-22 systems win unlock long-term defense upside? Read what this means for Nasdaq: MOBX, investor sentiment, and aerospace growth.
How Hyperscale Data, Inc.’s settlement-driven cash influx may reset the market’s liquidity debate (NYSE American: GPUS)
Find out how Hyperscale Data, Inc.’s $26.6 million settlement cash influx could reshape liquidity, funding flexibility, and investor sentiment today.
Why NUBURU, Inc.’s Asia-Pacific defense order could accelerate its counter-drone growth story (NYSE American: BURU)
Find out why NUBURU, Inc.’s Asia-Pacific defense order could become a key turning point in the global counter-drone market. Read the full executive analysis.
The AI race just got more physical: Why Corning Incorporated and Meta Platforms, Inc. are pouring money into cable, not just chips (NYSE: GLW, Nasdaq: META)
Corning Incorporated and Meta Platforms, Inc. are expanding AI cable manufacturing in North Carolina. Read why this matters for supply chains and investors.
Does CADENCE confirm a scalable pathway for treating complex pulmonary vascular disease beyond pulmonary arterial hypertension?
WINREVAIR’s Phase 2 data signals expansion beyond pulmonary arterial hypertension. Find out what this means for Merck & Co., Inc. and the market.